May 2022, Vol 8, No. 5, Pages 669-788

This cohort study uses data from the Surveillance, Epidemiology, and End Results database to identify clinical, sociodemographic, and structural processes underlying racial disparity in the use of prostate magnetic resonance imaging among men with a new diagnosis of prostate cancer.

This randomized clinical trial compare the efficacy of HD201 with referent trastuzumab for treating patients with ERBB2-positive breast cancer.

This phase 3 randomized clinical trial examines whether induction chemotherapy with paclitaxel, cisplatin, and capecitabine improves survival vs cisplatin and fluorouracil prior to chemoradiotherapy for patients with stage IVA to IVB nasopharyngeal carcinoma.

This cohort study examines patterns of guideline-concordant treatment among patients enrolled in a US-wide screening protocol for adjuvant treatment trials for resected non-small cell lung cancer.

This case-control study examines the use of a measure estimating the association between cumulative lifetime exposure to excess weight and the risk for colorectal cancer.

This randomized clinical trial investigates whether carotuximab plus pazopanib improves progression-free survival vs pazopanib alone in adult patients with advanced angiosarcoma.

This case-control study examines the associations between patient-reported outcome measures and subsequent nonfatal self-injury in patients with cancer.

This comparative effectiveness study of immunocompromised patients and healthy controls in Switzerland examines differences in the magnitude and durability of neutralizing antibody responses against the original SARS-CoV-2 and several variants of concern according to the mRNA-1273 and BNT162b2 vaccines.